
Bluesign introduces concept to phase out critical solvents
Switzerland-based Bluesign Technologies has introduced its newest concept to address and phase-out harsh carcinogenic, mutagenic or toxic to reproduction (CMR) solvents.

Switzerland-based Bluesign Technologies has introduced its newest concept to address and phase-out harsh carcinogenic, mutagenic or toxic to reproduction (CMR) solvents.